Among them, miR-199b was the most significantly inhibited

Among them, miR-199b was the most significantly inhibited. Aerosol delivery of miR-199b to the lung of mice. a Gene delivery efficiency Cilnidipine of PCAmHn as a gene carrier. Delivery efficiency of PCAmHn as a gene carrier was evaluated using PCAmHn/green fluorescent protein (GFP) expression plasmid complex. ICR mice were exposed to aerosol containing PCAmHn/GFP expression plasmid complex or GFP expression plasmid only for 30 minuets, and 72 hours post-treatment, the mice were sacrificed for delivery efficiency assay. Green signals indicated that most of the delivered GFP was efficiently trasfected into lung. b miR-199b expression was measured in the lung tissue of K-RasLA1 transgenic mice. Control mice were exposed to the gene carrier only (carrier); Vector group mice were exposed to vector mixed with the gene carrier (vector); miR-199b group mice were exposed to the miR-199b expression plasmid mixed with the gene carrier (miR-199b). Figure S4 The protein levels of miR-199b candidate targets in NSCLC cells and the lungs of K-RasLA1 transgenic mice. a. The expression levels of the indicated proteins in Fig. ?Fig.4e4e were quantified using image J software. b. The expression levels of the indicated proteins in Fig. ?Fig.4f4f were quantified using image J software. *,p 0.05 compare to carrier control; **, p 0.01 compared to carrier control; #, p 0.05 compared to vector control; ##, p 0.01 compared to carrier control. Figure S5 The protein levels of Akt and ERK signaling pathway related genes in NSCLC cells. a. The expression levels of the indicated proteins in Fig. ?Fig.5a5a were quantified using image J software. b. The expression levels of the indicated proteins in Fig. ?Fig.5c5c were quantified using image J software. (PPTX 820 kb) 13046_2019_1170_MOESM1_ESM.docx (13K) GUID:?FB3A421B-FB1F-497C-8CCC-08228807C1A5 Data Availability StatementAll data generated of analyzed during this study are included in this published article and its supplementary information files. The datasets generated and Cilnidipine used in this study are available from your related author on sensible request. Abstract Background miRNAs play important part in the progression of K-Ras-mutated nonsmall cell lung malignancy (NSCLC). However, most studies possess focused on miRNAs that target K-Ras. Here, we investigated miRNAs controlled by mutant K-Ras and their functions. Methods miRNAs controlled by mutant K-Ras were screened using miRNA arrays. miR-199b manifestation levels were measured by qRT-PCR. The protein manifestation levels were measured using Western blot and immunohistochemistry. The effects of miR-199b on NSCLC were examined both in vitro and in vivo by overexpressing or inhibiting miR-199b. DNA methylation was measured by bisulfite sequencing. Results An inverse correlation was observed between K-Ras mutation status and miR-199b levels in NSCLC specimens and cell lines. The inhibition of miR-199b stimulated NSCLC growth and metastasis, while repair of miR-199b suppressed K-Ras mutation-driven lung tumorigenesis as well as K-Ras-mutated NSCLC growth and metastasis. miR-199b inactivated ERK and Akt pathways by focusing on K-Ras, KSR2, PIK3R1, Akt1, and Rheb1. Furthermore, we identified that mutant K-Ras inhibits miR-199b manifestation by increasing miR-199b promoter methylation. Summary Our findings suggest that mutant K-Ras takes on an oncogenic part through downregulating Cilnidipine miR-199b in NSCLC and that overexpression of miR-199b is definitely a novel strategy for the treatment of K-Ras-mutated NSCLC. Electronic supplementary material The online version of this article (10.1186/s13046-019-1170-7) contains supplementary material, which is Cilnidipine available to authorized users. value of less than 0.05. Results miR-199b manifestation was negatively controlled by mutant K-Ras in NSCLC To identify miRNAs that are controlled by mutant K-Ras in NSCLC, we performed miRNA array assays using the K-Ras (G12D)-overexpressing NSCLC cell lines H1975 and H522, as well as their vector control cells. As demonstrated in Fig.?1a, we detected a total of 46 miRNAs that were significantly decreased by K-Ras (G12D) overexpression in both NSCLC cell lines compared to the respective control cells. Among them, miR-199b was the most significantly inhibited. Consistent with miRNA array results, clinical samples and NSCLC cell collection analysis results showed that miR-199b was dramatically decreased in K-Ras-mutated NSCLC specimens and cell lines compared to crazy- type K-Ras NSCLC specimens and cell lines (Fig. ?(Fig.1b1b and c). Additionally, we shown decreased manifestation of miR-199b in K-Ras-mutated NSCLC specimens compared to their adjacent Pdpn cells Cilnidipine (Fig. ?(Fig.1d).1d). However, we did not.